What is a primary design consideration for drug-coated balloons (DCB)?

• A. Design for long-term release
• B. Targeted transfer
• C. Minimal interaction with stent materials
• D. Enhanced visual tracking during procedures

Answer: (B)

The primary design consideration for drug-coated balloons (DCBs) centers around targeted transfer. DCBs are specifically engineered to deliver localized therapeutic agents directly to the vessel walls during the dilation process in procedures such as angioplasty. This targeted approach is crucial as it minimizes systemic exposure to the drug while maximizing its effectiveness at the site of treatment, which in turn helps to reduce the recurrence of restenosis, a common issue in vascular interventions.

Focusing on targeted transfer ensures that the drug is efficiently transferred to the problematic area within the blood vessel, thereby optimizing the therapeutic effect of the drug while reducing potential side effects and complications associated with systemic drug delivery. This aspect of DCB design is critical to its function and distinguishes it from other methods of drug delivery in vascular treatments.

While other design considerations such as long-term release, interaction with stent materials, and enhanced visual tracking during procedures are important factors in the broader scope of vascular interventions, they are not as central to the specific function and efficacy of DCBs as targeted transfer is.